Fig. 4From: Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacyCAR-T cells that secrete the anti-CD40 antibody have enhanced antitumor function in vivo. a Bioluminescence signals from SKOV-3-luc cancer model mice during treatment. b The quantified fluorescence intensities of SKOV-3-luc for individual mice are shown in the line graphs. c The fluorescence intensity of SKOV-3-luc was analysed (n = 6, medians with range, Mann–Whitney test, *P < 0.05). d The body weights of individual mice were recorded and are shown in the line graphsBack to article page